 | Up a level |
Popp, Albrecht; Varathan, Nadshathra; Buffat, Helene; Senn, Christoph; Perrelet, Romain; Lippuner, Kurt (2018). Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis. Calcified tissue international, 103(1), pp. 50-54. Springer 10.1007/s00223-018-0394-4
Popp, Albrecht; Meer, Salome; Krieg, Marc-Antoine; Perrelet, Romain; Hans, Didier; Lippuner, Kurt (2016). Bone mineral density (BMD) and vertebral trabecular bone score (TBS) for the identification of elderly women at high risk for fracture: the SEMOF cohort study. European spine journal, 25(11), pp. 3432-3438. Springer 10.1007/s00586-015-4035-6
Senn, Christoph; Günther, Beatrice; Popp, Albrecht; Perrelet, Romain; Hans, D; Lippuner, Kurt (2014). Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporosis international, 25(7), pp. 1945-1951. Springer 10.1007/s00198-014-2703-8
Del Pozo, Emilio; Janner, Marco; Mackenzie, Andrew R; Arampatzis, Spyridon; Dixon, Arnold K; Perrelet, Romain; Ruch, Walter; Lippuner, Kurt; Zapf, Juergen; Lamberts, Steven W; Mullis, Primus-Eugen (2014). Radiometrical, hormonal and biological correlates of skeletal growth in the female rat from birth to senescence. Growth hormone & IGF research, 24(2-3), pp. 83-88. Elsevier 10.1016/j.ghir.2014.03.003
Lippuner, K; Grifone, S; Schwenkglenks, M; Schwab, P; Popp, A W; Senn, C; Perrelet, Romain (2012). Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporosis international, 23(3), pp. 829-39. London: Springer-Verlag 10.1007/s00198-011-1660-8
Lippuner, K; Popp, A W; Schwab, P; Gitlin, M; Schaufler, T; Senn, C; Perrelet, Romain (2011). Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis. Osteoporosis international, 22(9), pp. 2487-97. London: Springer-Verlag 10.1007/s00198-010-1487-8
Popp, A W; Senn, C; Franta, O; Krieg, M A; Perrelet, Romain; Lippuner, K (2009). Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women. Osteoporosis international, 20(8), pp. 1393-9. London: Springer-Verlag 10.1007/s00198-008-0808-7
Reid, DM; Devogelaer, JP; Saag, K; Roux, C; Lau, CS; Reginster, JY; Papanastasiou, P; Ferreira, A; Hartl, F; Fashola, T; Mesenbrink, P; Sambrook, PN; Perrelet, Romain; HORIZON, investigators (2009). Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet, 373(9671), pp. 1253-1263. London: Elsevier 10.1016/S0140-6736(09)60250-6
Gasser, KM; Mueller, C; Zwahlen, M; Kaufmann, M; Fuchs, G; Perrelet, Romain; Abetel, G; Bürgi, U; Lippuner, K (2005). Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry. Osteoporosis international, 16(11), pp. 1353-62. London: Springer-Verlag 10.1007/s00198-005-1846-z
del Pozo, E; Popp, A W E; MacKenzie, A; Perrelet, Romain; Lamberts, S W J; Lippuner, K (2005). Graded doses of recombinant interleukin-1beta induce generalized osteopenia in rats without altering skeletal growth and joint integrity. Hormone research, 64(2), pp. 88-95. Basel: Karger 10.1159/000088169
Zehnder, Yvonne; Risi, Simone; Michel, Dieter; Knecht, Hans; Perrelet, Romain; Kraenzlin, Marius; Zäch, Guido A; Lippuner, Kurt (2004). Prevention of bone loss in paraplegics over 2 years with alendronate. Journal of bone and mineral research, 19(7), pp. 1067-74. Hoboken, N.J.: Wiley-Blackwell 10.1359/JBMR.040313
Zehnder, Yvonne; Lüthi, Markus; Michel, Dieter; Knecht, Hans; Perrelet, Romain; Neto, Isolde; Kraenzlin, Marius; Zäch, Guido; Lippuner, Kurt (2004). Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporosis international, 15(3), pp. 180-9. London: Springer-Verlag 10.1007/s00198-003-1529-6
Lippuner, Kurt; Perrelet, Romain; Casez, Jean-Paul; Popp, Albrecht; Uskokovic, Milan R; Jaeger, Philippe (2004). 1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect. Hormone research, 61(1), pp. 7-16. Basel: Karger 10.1159/000075191
Lippuner, K; Fuchs, G; Ruetsche, A G; Perrelet, Romain; Casez, J P; Neto, I (2000). How well do radiographic absorptiometry and quantitative ultrasound predict osteoporosis at spine or hip? A cost-effectiveness analysis. Journal of clinical densitometry, 3(3), pp. 241-9. New York, N.Y.: Elsevier 10.1385/JCD:3:3:241
Lippuner, K; von Overbeck, J; Perrelet, Romain; Bosshard, H; Jaeger, P (1997). Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporosis international, 7(5), pp. 414-25. London: Springer 10.1007/PL00004149
del Pozo, E; Gubler, H U; Perrelet, Romain; Hager, T; Wiederhold, K H (1988). Non-invasive quantitative estimation of bone density in rats throughout the life cycle and in arthritic osteopenia: preliminary results. Hormone and metabolic research, 20(10), pp. 630-2. Stuttgart: Thieme 10.1055/s-2007-1010902
